Recombinant multi-species PEBP1/RKIP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PEBP1/RKIP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the phosphatidylethanolamine-binding family of proteins and has been shown to modulate multiple signaling pathways, including the MAP kinase (MAPK), NF-kappa B, and glycogen synthase kinase-3 (GSK-3) signaling pathways. The encoded protein can be further processed to form a smaller cleavage product, hippocampal cholinergic neurostimulating peptide (HCNP), which may be involved in neural development. This gene has been implicated in numerous human cancers and may act as a metastasis suppressor gene. Multiple pseudogenes of this gene have been identified in the genome. [provided by RefSeq, Jul 2015]
The Alternative Names of target: HCNP,HCNPpp,HEL-210,HEL-S-34,HEL-S-96,Neuropolypeptide h3,PBP,PEBP,PEBP-1,PEBP1,Pbp,Pbp1,Pbpr,Pebp1,Phosphatidylethanolamine-binding protein 1,Prostatic-binding protein,RKIP,Raf kinase inhibitor protein (RKIP),Rkip

Target products collectionGo to PEBP1/RKIP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0144-Ag-1/ GM-Tg-hg-IP0144-Ag-2 Human PEBP1/RKIP protein Human
GM-Tg-rg-IP0144-Ag-1/ GM-Tg-rg-IP0144-Ag-2 Rat PEBP1/RKIP protein Rat
GM-Tg-mg-IP0144-Ag-1/ GM-Tg-mg-IP0144-Ag-2 Mouse PEBP1/RKIP protein Mouse
GM-Tg-cynog-IP0144-Ag-1/ GM-Tg-cynog-IP0144-Ag-2 Cynomolgus/Rhesus macaque PEBP1/RKIP protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0144-Ag-1/ GM-Tg-felg-IP0144-Ag-2 Feline PEBP1/RKIP protein Feline
GM-Tg-cang-IP0144-Ag-1/ GM-Tg-cang-IP0144-Ag-2 Canine PEBP1/RKIP protein Canine
GM-Tg-bovg-IP0144-Ag-1/ GM-Tg-bovg-IP0144-Ag-2 Bovine PEBP1/RKIP protein Bovine
GM-Tg-equg-IP0144-Ag-1/ GM-Tg-equg-IP0144-Ag-2 Equine PEBP1/RKIP protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0144-Ag-1/ GM-Tg-hg-IP0144-Ag-2; GM-Tg-rg-IP0144-Ag-1/ GM-Tg-rg-IP0144-Ag-2;
GM-Tg-mg-IP0144-Ag-1/ GM-Tg-mg-IP0144-Ag-2; GM-Tg-cynog-IP0144-Ag-1/ GM-Tg-cynog-IP0144-Ag-2;
GM-Tg-felg-IP0144-Ag-1/ GM-Tg-felg-IP0144-Ag-2; GM-Tg-cang-IP0144-Ag-1/ GM-Tg-cang-IP0144-Ag-2;
GM-Tg-bovg-IP0144-Ag-1/ GM-Tg-bovg-IP0144-Ag-2; GM-Tg-equg-IP0144-Ag-1/ GM-Tg-equg-IP0144-Ag-2
Products Name PEBP1/RKIP protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PEBP1/RKIP
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PEBP1/RKIP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.